Ultrasound Nanobubbles Crack Prostate Cancer’s Collagen Fortress Improving Immunotherapy Penetration

Researchers at Case Western Reserve University used tiny ultrasound-activated nanobubbles to dismantle the tough collagen walls that shield solid tumors from treatments. These “fortresses” made of stiff, crosslinked collagen block immune cells and drugs from reaching cancer cells deep inside, a major hurdle in fighting aggressive tumors like prostate cancer. The nanobubbles, filled with inert perfluoropropane gas, are injected intravenously and targeted to tumors; a quick ultrasound pulse (1 MHz, 1.5 MPa) then jiggles them, disrupting collagen alignment and softening the matrix by 60% without harming healthy cells. This effect lasts over five days after just one treatment.

The rationale is straightforward: tumors stiffen their stroma to evade therapies, much like a fortress repels invaders. In lab models of breast cancer, this method randomized collagen fibers, reduced new deposition fivefold, and activated resident immune cells to release signals drawing in T cells from afar,even shrinking untreated metastases. When paired with lipid nanoparticles carrying RNA to boost T-cell attacks, the bubbles allowed even distribution inside tumors instead of mere surface sticking, turning immunotherapy-resistant “cold” tumors hotter and more responsive.

For prostate cancer, where dense stroma and immune exclusion doom many drugs, this is especially exciting. Ultrasound is already routine and FDA-approved for prostate imaging, making translation feasible. The same team’s nanobubbles underpin PSMA-targeted detection and cavitation therapies for prostate tumors, selectively bursting PSMA-positive cells. Precedents include plasmonic nanobubbles that rapidly kill drug-resistant prostate cancers via targeted bursts. With an IND filing planned within 18 months and trials in two years for prostate, liver, and ovarian cancers, this could supercharge immunotherapies and nanoparticles long stalled by barriers.

Source.